Business
Press Release Jun 14 2021
Cadila Healthcare Limited has informed the Exchange regarding a press release dated Jun 14, 2021, titled "Zydus Cadila receives tentative approval from USFDA for Brivaracetam Tablets".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Cadila Healthcare Limited has informed the Exchange regarding a press release dated Jun 14, 2021, titled \"Zydus Cadila receives tentative approval from USFDA for Brivaracetam Tablets\". View Attachment","length":337,"tagName":"div"}]